Research
area

Research holds a fundamental place at Unicancer, encompassing the fields of clinical research, translational research, and health data. Its methodical and organized approach aims to place innovation at the service of patients.

Over 700 active clinical trials sponsored

Major player in oncology in France and internationally, Unicancer benefits from the strength of a dynamic, engaged, and pioneering network.

En cours d’ouverture

Expert group : Sarcome

  • Sarcome
  • Os
  • Tissus mous

INTER-EWING 1

Programme de recherche clinique international pour améliorer la prise en charge des patients nouvellement diagnostiqués d’un sarcome d’Ewing

Principal investigator : Pr Bernadette Brennan (Royaume-Uni) / Dr Nathalie Gaspar (France)

Etude Phase III

Sponsor : Université de Birmingham, Royaume-Uni

Unicancer Contact Marta Jimenez

En cours de recrutement

Expert group : MED PERSO

  • Voies biliaires

SAFIR ABC10

Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, platform phase 3 trial

Principal investigator : Dr David MALKA

Etude Phase III

Sponsor : UNICANCER

Unicancer Contact MARTA JIMENEZ

En cours de recrutement

Expert group : SARCOME

  • Utérus
  • Sarcome

L-UTECIN

Interest of adjuvant chemotherapy in patients with CINSARC high-risk localized resected uterine leiomyosarcoma

Principal investigator : Pr Florence DUFFAUD

Etude Phase II

Sponsor : UNICANCER

Unicancer Contact Marta JIMENEZ

10 expert groups, including 6 accredited by INCa

Synonyms of Unicancer’s research excellence: 10 expert groups work daily to advance cancer research.

Unicancer
Research Groups

Organs and cross-functional teams
Transversal Groups